 |
The Journal of Neuroscience, October 11, 2006, 26(41):10536-10541; doi:10.1523/JNEUROSCI.3133-06.2006
Previous Article | Next Article 
Brief Communications
p25/Cyclin-Dependent Kinase 5 Induces Production and Intraneuronal Accumulation of Amyloid In Vivo
Jonathan C. Cruz,1 *
Dohoon Kim,1 *
Lily Y. Moy,1
Matthew M. Dobbin,1
Xiaoyan Sun,2
Roderick T. Bronson,3 and
Li-Huei Tsai1
1Department of Pathology, Harvard Medical School and Howard Hughes Medical Institute, Boston, Massachusetts 02115, and 2Center for Neurologic Diseases, Brigham and Women's Hospital, Program in Neuroscience, and 3Rodent Histopathology Core, Harvard Medical School, Boston, Massachusetts 02115
Correspondence should be addressed to Li-Huei Tsai at her present address: Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Boston, MA 02139. Email: lhtsai{at}mit.edu
Aberrant processing of the amyloid precursor protein (APP) and the subsequent accumulation of amyloid (A ) peptide has been widely established as a central event in Alzheimer's disease (AD) pathogenesis. The sequential cleavage steps required for the generation of A are well outlined; however, there is a relative dearth of knowledge pertaining to signaling pathways and molecular mechanisms that can modulate this process. Here, we demonstrate a novel role for p25/cyclin-dependent kinase 5 (Cdk5) in regulating APP processing, A peptide generation, and intraneuronal A accumulation in inducible p25 transgenic and compound PDAPP transgenic mouse models that demonstrate deregulated Cdk5 activity and a neurodegenerative phenotype. Induction of p25 resulted in enhanced forebrain A levels before any evidence of neuropathology in these mice. Intracellular A accumulated in perinuclear regions and distended axons within the forebrains of these mice. Evidence for modulations in axonal transport or -site APP cleaving enzyme 1 protein levels and activity are presented as mechanisms that may account for the A accumulation caused by p25/Cdk5 deregulation. Collectively, these findings delineate a novel pathological mechanism involving aberrant APP processing by p25/Cdk5 and have important implications in AD pathogenesis.
Key words: Alzheimer's disease; amyloid ; BACE1; cdk5; neurodegeneration; p25
Received Oct. 15, 2005;
accepted Sept. 6, 2006.
Correspondence should be addressed to Li-Huei Tsai at her present address: Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Boston, MA 02139. Email: lhtsai{at}mit.edu
This article has been cited by other articles:

|
 |

|
 |
 
K.-H. Sun, H.-g. Lee, M. A. Smith, and K. Shah
Direct and Indirect Roles of Cyclin-dependent Kinase 5 as an Upstream Regulator in the c-Jun NH2-Terminal Kinase Cascade: Relevance to Neurotoxic Insults in Alzheimer's Disease
Mol. Biol. Cell,
November 1, 2009;
20(21):
4611 - 4619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Tampellini, N. Rahman, E. F. Gallo, Z. Huang, M. Dumont, E. Capetillo-Zarate, T. Ma, R. Zheng, B. Lu, D. M. Nanus, et al.
Synaptic Activity Reduces Intraneuronal A{beta}, Promotes APP Transport to Synapses, and Protects against A{beta}-Related Synaptic Alterations
J. Neurosci.,
August 5, 2009;
29(31):
9704 - 9713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ding, A. Qiao, Z. Wang, J. S. Goodwin, E.-S. Lee, M. L. Block, M. Allsbrook, M. P. McDonald, and G.-H. Fan
Retinoic Acid Attenuates {beta}-Amyloid Deposition and Rescues Memory Deficits in an Alzheimer's Disease Transgenic Mouse Model
J. Neurosci.,
November 5, 2008;
28(45):
11622 - 11634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sakurai, K. Kaneko, M. Okuno, K. Wada, T. Kashiyama, H. Shimizu, T. Akagi, T. Hashikawa, and N. Nukina
Membrane microdomain switching: a regulatory mechanism of amyloid precursor protein processing
J. Cell Biol.,
October 20, 2008;
183(2):
339 - 352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kaminosono, T. Saito, F. Oyama, T. Ohshima, A. Asada, Y. Nagai, N. Nukina, and S.-i. Hisanaga
Suppression of Mutant Huntingtin Aggregate Formation by Cdk5/p35 through the Effect on Microtubule Stability
J. Neurosci.,
August 27, 2008;
28(35):
8747 - 8755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Iijima-Ando, S. A. Hearn, L. Granger, C. Shenton, A. Gatt, H.-C. Chiang, I. Hakker, Y. Zhong, and K. Iijima
Overexpression of Neprilysin Reduces Alzheimer Amyloid-{beta}42 (A{beta}42)-induced Neuron Loss and Intraneuronal A{beta}42 Deposits but Causes a Reduction in cAMP-responsive Element-binding Protein-mediated Transcription, Age-dependent Axon Pathology, and Premature Death in Drosophila
J. Biol. Chem.,
July 4, 2008;
283(27):
19066 - 19076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-H. Sun, Y. de Pablo, F. Vincent, E. O. Johnson, A. K. Chavers, and K. Shah
Novel Genetic Tools Reveal Cdk5's Major Role in Golgi Fragmentation in Alzheimer's Disease
Mol. Biol. Cell,
July 1, 2008;
19(7):
3052 - 3069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wen, E. Planel, M. Herman, H. Y. Figueroa, L. Wang, L. Liu, L.-F. Lau, W. H. Yu, and K. E. Duff
Interplay between Cyclin-Dependent Kinase 5 and Glycogen Synthase Kinase 3{beta} Mediated by Neuregulin Signaling Leads to Differential Effects on Tau Phosphorylation and Amyloid Precursor Protein Processing
J. Neurosci.,
March 5, 2008;
28(10):
2624 - 2632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Miller, M. C. Oldham, and D. H. Geschwind
A Systems Level Analysis of Transcriptional Changes in Alzheimer's Disease and Normal Aging
J. Neurosci.,
February 6, 2008;
28(6):
1410 - 1420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Flajolet, G. He, M. Heiman, A. Lin, A. C. Nairn, and P. Greengard
Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I
PNAS,
March 6, 2007;
104(10):
4159 - 4164.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|